Cargando…
Anticoagulant Activities of Indobufen, an Antiplatelet Drug
Indobufen is a new generation of anti-platelet aggregation drug, but studies were not sufficient on its anticoagulant effects. In the present study, the anticoagulant activity of indobufen was determined by monitoring the activated partial thromboplastin time (APTT), prothrombin time (PT), and throm...
Autores principales: | Liu, Jia, Xu, Dan, Xia, Nian, Hou, Kai, Chen, Shijie, Wang, Yu, Li, Yunman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099839/ https://www.ncbi.nlm.nih.gov/pubmed/29914049 http://dx.doi.org/10.3390/molecules23061452 |
Ejemplares similares
-
Reversible and Non-Competitive Inhibition of Cyclooxygenase by Indobufen for Efficient Antiplatelet Action and Relief of Gastrointestinal Irritation
por: Liu, Jia, et al.
Publicado: (2023) -
Prediction of the human in vivo antiplatelet effect of S- and R-indobufen using population pharmacodynamic modeling and simulation based on in vitro platelet aggregation test
por: Noh, Yook-Hwan, et al.
Publicado: (2018) -
Comparison of the prophylactic antithrombotic effect of indobufen and warfarin in patients with nephrotic syndrome: a randomized controlled trial
por: Gao, Xin-Yi, et al.
Publicado: (2023) -
Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
por: Pan, Yuesong, et al.
Publicado: (2022) -
Hypersensitivity reactions to modern antiplatelet and anticoagulant drugs
por: Hofmeier, Kathrin Scherer
Publicado: (2015)